{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:52:03Z","timestamp":1790099523079,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL151367"],"award-info":[{"award-number":["HL151367"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.thromres.2022.05.012","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T22:16:50Z","timestamp":1653603410000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis"],"prefix":"10.1016","volume":"216","author":[{"given":"Hannah","family":"McMurry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.G.","family":"Sabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Elstrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Chobrutskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Mohinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylee","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Shatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2022.05.012_bb0005","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999\u20132016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.thromres.2022.05.012_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/ejh.13688","article-title":"The hemostatic and thrombotic complications of liver disease","volume":"107","author":"McMurry","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/asheducation-2015.1.243","article-title":"Coagulopathy in liver disease: a balancing act","volume":"2015","author":"Kujovich","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.thromres.2022.05.012_bb0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2022.05.012_bb0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","author":"Tripodi","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.05.012_bb0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/jth.12805","article-title":"Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan","volume":"13","author":"Ng","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.05.012_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study","volume":"104","author":"Sogaard","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0040","first-page":"315","article-title":"Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges","volume":"31","author":"Mantaka","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/VHRM.S197732","article-title":"Splanchnic vein thrombosis: current perspectives","volume":"15","author":"Valeriani","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.thromres.2022.05.012_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11739-008-0128-0","article-title":"Portal vein thrombosis in liver cirrhosis","volume":"3","author":"Fimognari","year":"2008","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.thromres.2022.05.012_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-7-34","article-title":"Portal vein thrombosis; risk factors, clinical presentation and treatment","volume":"7","author":"Sogaard","year":"2007","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0060","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0065","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","author":"Amitrano","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0070","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/MEG.0000000000001982","article-title":"Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study","volume":"33","author":"Nery","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0075","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2022.05.012_bb0080","doi-asserted-by":"crossref","unstructured":"C Noronha Ferreira D Reis H Cortez-Pinto et al Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis. Digestive Diseases and Sciences;64:2671-2683.","DOI":"10.1007\/s10620-019-05572-z"},{"key":"10.1016\/j.thromres.2022.05.012_bb0085","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.thromres.2022.05.012_bb0090","article-title":"The impact of portal vein thrombosis on the prognosis of patients with cirrhosis: a retrospective propensity-score matched study","volume":"8","author":"Chen","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.thromres.2022.05.012_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025439","article-title":"Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: a systematic review and meta-analysis","volume":"100","author":"Xian","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.thromres.2022.05.012_bb0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cgh.2014.10.010","article-title":"Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis","volume":"13","author":"Berry","year":"2015","journal-title":"Clin.Gastroenterol.Hepatol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1319-3767.141687","article-title":"Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients","volume":"20","author":"Girleanu","year":"2014","journal-title":"Saudi J. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0110","article-title":"Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis","volume":"114","author":"Pettinari","year":"2019","journal-title":"Off. J. Am. Coll. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-term outcome of splanchnic vein thrombosis in cirrhosis","volume":"9","author":"Senzolo","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","article-title":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"26","author":"Qi","year":"2015","journal-title":"Eur.J.Intern.Med."},{"key":"10.1016\/j.thromres.2022.05.012_bb0125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12325-020-01550-4","article-title":"Anticoagulation favors thrombus recanalization and survival in patients with liver cirrhosis and portal vein thrombosis: results of a meta-analysis","volume":"38","author":"Wang","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.thromres.2022.05.012_bb0130","first-page":"104","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"34","author":"Ghazaleh","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: disorders of the hepatic and mesenteric circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Electronic address eee. EASL clinical practice guidelines: vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00535-021-01788-x","article-title":"Evidence-based clinical practice guidelines for liver cirrhosis 2020","volume":"56","author":"Yoshiji","year":"2021","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2022.05.012_bb0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12916-018-1069-8","article-title":"Transient portal vein thrombosis in liver cirrhosis","volume":"16","author":"Qi","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.thromres.2022.05.012_bb0170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"480\u2013487","key":"10.1016\/j.thromres.2022.05.012_bb0175","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.thromres.2022.05.012_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2018.12.019","article-title":"Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: a retrospective cohort study","volume":"174","author":"Acuna-Villaorduna","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2022.05.012_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/245460","article-title":"Prevalence of splanchnic vein thrombosis in pancreatitis: a systematic review and meta-analysis of observational studies","volume":"2015","author":"Xu","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.thromres.2022.05.012_bb0190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14740\/gr1223","article-title":"Splanchnic venous thrombosis in acute pancreatitis: does anticoagulation affect outcome?","volume":"13","author":"Junare","year":"2020","journal-title":"Gastroenterol.Res."},{"key":"10.1016\/j.thromres.2022.05.012_bb0195","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1477-2574.2011.00392.x","article-title":"Splanchnic vein thrombosis in severe acute pancreatitis: a 2-year, single-institution experience","volume":"13","author":"Gonzelez","year":"2011","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.thromres.2022.05.012_bb0200","article-title":"Outcomes of anticoagulation for portal and\/or splenic vein thrombosis in setting of acute pancreatitis: 11","volume":"112","author":"Anderson","year":"2017","journal-title":"Off. J. Am. Coll. Gastroenterol."},{"issue":"2","key":"10.1016\/j.thromres.2022.05.012_bb0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pan.2021.12.008","article-title":"Therapeutic anticoagulation for splanchnic vein thrombosis in acute pancreatitis: a systematic review and meta-analysis","volume":"22","author":"Sissingh","year":"2021","journal-title":"Pancreatology"},{"key":"10.1016\/j.thromres.2022.05.012_bb0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study","volume":"38","author":"Stine","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.thromres.2022.05.012_bb0215","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0220","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.thromres.2022.05.012_bb0225","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.3748\/wjg.v25.i31.4437","article-title":"Portal vein thrombosis in cirrhosis: why a well-known complication is still matter of debate","volume":"25","author":"Faccia","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.thromres.2022.05.012_bb0230","unstructured":". !!! INVALID CITATION !!! 13."},{"key":"10.1016\/j.thromres.2022.05.012_bb0235","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2022.05.012_bb0240","unstructured":". !!! INVALID CITATION !!! 11-16."},{"key":"10.1016\/j.thromres.2022.05.012_bb0245","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood.2020006827","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"137","author":"Valeriani","year":"2021","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482200278X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482200278X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:48:43Z","timestamp":1758736123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482200278X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":49,"alternative-id":["S004938482200278X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.05.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}